The Case for Electronic Cancel or Discontinuation of Prescription Therapy at the Pharmacy

Study Type/ Setting Methods Outcomes Recommendations Source
Article Objective was to focus on integration of cancel Rx both from provider end and pharmacy end to reduce inappropriate therapy

 

- Study conducted in Brigham and Women’s - 1.5% of all discontinued prescription medications in their target medication study sample were dispensed by pharmacies.            - More importantly, investigators reported at least 50 patients, or 12% of those receiving discontinued medications, had experienced some adverse outcome that ranged from mild side effects to life-threatening allergic reactions. Prescribers and pharmacists should reach out to their software technology providers and convey to them the urgency and the need to implement the CancelRx /Response Rx transaction capability Dhavel A 

 

 

Dhavel A. The Case for Electronic Cancel or Discontinuation of Prescription Therapy at the Pharmacy. LinkedIn. https://www.linkedin.com/pulse/case-electronic-canceldiscontinuation-prescription-therapy-dhavle. Accessed May 27, 2019.